The administration of scopolamine, an antagonist of muscarinic acetylcholine receptors, causes a temporary blockade of receptors, impaired cognitive functions and cerebral metabolism, which is considered to be a reliable model of AD (Buccafusco, 2009 ). Scopolamine aqueous solution was prepared by dissolving weighed sample in water for injection. A solution of scopolamine was injected intraperitoneally at a dose of 1.5 mg/kg/5 mL once 30 min before testing of the passive avoidancereflex (only on the first day - the day of training).
Free full text: Click here